Transgene Biotek share news and announcements
BSE: 526139Healthcare ServicesSmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹2.37.
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹19 Cr4,238th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 2.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- −17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- −2.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 2.05
- Volume, BSEVolume. Shares traded on the last trading day.
- 26,565
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Transgene Biotek quarterly results
The board met on 7 Aug 2026 to consider quarterly results
Notice filed 23 Jul 2026
Transgene Biotek annual reports, presentations and earnings calls
The company's own documents, latest first.Transgene Biotek financials, year by year
Annual reports26
- Annual report, year to Mar 2025 (opens in a new tab)5 Dec 2025
- Annual report, year to Mar 2024 (opens in a new tab)12 Nov 2024
- Annual report, 2023 (opens in a new tab)1 Dec 2023
- Annual report, year to Mar 2022 (opens in a new tab)2 Sep 2022
- Annual report, year to Mar 2021 (opens in a new tab)31 Aug 2021
21 earlier reports
- Annual report, year to Mar 2020 (opens in a new tab)28 Aug 2020
- Annual report, year to Mar 2019 (opens in a new tab)7 Sep 2019
- Annual report, year to Mar 2018 (opens in a new tab)31 Dec 2018
- Annual report, year to Mar 2017 (opens in a new tab)15 Nov 2017
- Annual report, year to Mar 2016 (opens in a new tab)12 Sep 2016
- Annual report, year to Mar 2014 (opens in a new tab)8 Mar 2016
- Annual report, year to Mar 2015 (opens in a new tab)12 Sep 2015
- Annual report, year to Mar 2013 (opens in a new tab)17 Sep 2013
- Annual report, year to Mar 2012 (opens in a new tab)1 Oct 2012
- Annual report, year to Mar 2011 (opens in a new tab)11 Nov 2011
- Annual report, year to Mar 2010 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2009 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2008 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2007 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2006 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2005 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2004 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2003 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2002 (opens in a new tab)Filing day not known
- Annual report, year to Mar 2000 (opens in a new tab)Filing day not known
- Annual report, year to Mar 1999 (opens in a new tab)Filing day not known
Transgene Biotek share news and announcements
482 announcements, routine notices left out, newest first. Page 1 of 10.
Oct 2026
5 Oct · Board meeting
Meeting on 10 Oct 20263 Oct · Compliance-57 (5) : intimation after the end of quarter
3 Oct · Compliance-57 (4) : Prior intimation to the beginning of the quarter
3 Oct · Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Sep 2026
Aug 2026
Jul 2026
23 Jul · Board meeting
Meeting on 7 Aug 2026: quarterly results22 Jul · Compliance-57 (4) : Prior intimation to the beginning of the quarter
22 Jul · Business
22 Jul · Compliance-57 (5) : intimation after the end of quarter
May 2026
29 May · Results
15 May · Board meeting
Meeting on 29 May 2026: audited results
Apr 2026
13 Apr · Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31St March 2026.
13 Apr · Compliance-57 (4) : Prior intimation to the beginning of the quarter
13 Apr · Compliance-57 (5) : intimation after the end of quarter
13 Apr · Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Feb 2026
3 Feb · Business
Jan 2026
28 Jan · Board meeting
Meeting on 13 Feb 2026: quarterly results12 Jan · Business
12 Jan · Compliance-57 (5) : intimation after the end of quarter
12 Jan · Compliance-57 (4) : Prior intimation to the beginning of the quarter
Dec 2025
30 Dec · Meeting
30 Dec · Meeting
30 Dec · Meeting
Nov 2025
14 Nov · Results
Oct 2025
31 Oct · Board meeting
Meeting on 14 Nov 2025: quarterly results17 Oct · Business
12 Oct · Compliance-57 (4) : Prior intimation to the beginning of the quarter
12 Oct · Compliance-57 (5) : intimation after the end of quarter
11 Oct · Business
Sep 2025
1 Sep · Subject: Intimation About The Initiation Of Insolvency Process. This Is To Inform About The Receipt Of Intimation Today From M/S Babaji Nethralayya Private Limited Initiating An Action Under Section 7 Of The Insolvency And Bankruptcy Code, 2016, Read With Rule 4 Of The Insolvency And Bankruptcy Board Of India (Application To Adjudicating Authority) Rules, 2016 For Corporate Insolvency Resolution Process.
Aug 2025
Jul 2025
30 Jul · Board meeting
Meeting on 7 Aug 2025: quarterly results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 24 Sep 2026Board or managers changeddown 2.61%−0.9 pts vs Nifty 500market median 0.0% · five sessions −3.7% (0.0 pts vs Nifty 500) · volume 3.2× usual · The announcement (opens in a new tab)
- 31 Dec 2024Order receiveddown 6.18%−6.3 pts vs Nifty 500market median +1.1% · five sessions −31.2% (−30.6 pts vs Nifty 500) · volume 1.4× usual · The announcement (opens in a new tab)
- 13 Jan 2015Board or managers changedup 1.03%+1.2 pts vs Nifty 500market median 0.0% · five sessions −4.1% (−6.7 pts vs Nifty 500) · volume 1.3× usual
- 12 Dec 2012Board or managers changeddown 1.87%−1.7 pts vs Nifty 500market median 0.0% · five sessions −9.1% (−9.4 pts vs Nifty 500) · volume 2.8× usual